-
2
-
-
37849046096
-
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours
-
Conroy H., Marshall N.A., and Mills K.H. TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 27 January 7 (2) (2008) 168-180
-
(2008)
Oncogene
, vol.27
, Issue.January 7 2
, pp. 168-180
-
-
Conroy, H.1
Marshall, N.A.2
Mills, K.H.3
-
3
-
-
37849035627
-
TLR signaling by tumor and immune cells: a double-edged sword
-
Huang B., Zhao J., Unkeless J.C., Feng Z.H., and Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27 2 (2008) 218-224
-
(2008)
Oncogene
, vol.27
, Issue.2
, pp. 218-224
-
-
Huang, B.1
Zhao, J.2
Unkeless, J.C.3
Feng, Z.H.4
Xiong, H.5
-
4
-
-
35748966158
-
PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool
-
Hornum L., Lundsgaard D., and Markholst H. PolyI:C induction of diabetes is controlled by Iddm4 in rats with a full regulatory T cell pool. Ann N Y Acad Sci 1110 (2007) 65-72
-
(2007)
Ann N Y Acad Sci
, vol.1110
, pp. 65-72
-
-
Hornum, L.1
Lundsgaard, D.2
Markholst, H.3
-
6
-
-
0033105695
-
Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
-
Steinbrink K., Jonuleit H., Muller G., Schuler G., Knop J., and Enk A.H. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells. Blood 93 5 (1999) 1634-1642
-
(1999)
Blood
, vol.93
, Issue.5
, pp. 1634-1642
-
-
Steinbrink, K.1
Jonuleit, H.2
Muller, G.3
Schuler, G.4
Knop, J.5
Enk, A.H.6
-
7
-
-
0042931259
-
+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism
-
+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism. J Immunol 171 5 (2003) 2251-2261
-
(2003)
J Immunol
, vol.171
, Issue.5
, pp. 2251-2261
-
-
Xu, S.1
Koski, G.K.2
Faries, M.3
Bedrosian, I.4
Mick, R.5
Maeurer, M.6
-
8
-
-
0030603986
-
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood
-
Bender A., Sapp M., Schuler G., Steinman R.M., and Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196 2 (1996) 121-135
-
(1996)
J Immunol Methods
, vol.196
, Issue.2
, pp. 121-135
-
-
Bender, A.1
Sapp, M.2
Schuler, G.3
Steinman, R.M.4
Bhardwaj, N.5
-
9
-
-
0033168630
-
Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells
-
Verdijk R.M., Mutis T., Esendam B., Kamp J., Melief C.J., Brand A., et al. Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. J Immunol 163 1 (1999) 57-61
-
(1999)
J Immunol
, vol.163
, Issue.1
, pp. 57-61
-
-
Verdijk, R.M.1
Mutis, T.2
Esendam, B.3
Kamp, J.4
Melief, C.J.5
Brand, A.6
-
10
-
-
0017108014
-
A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors
-
Robinson R.A., DeVita V.T., Levy H.B., Baron S., Hubbard S.P., and Levine A.S. A phase I-II trial of multiple-dose polyriboinosic-polyribocytidylic acid in patieonts with leukemia or solid tumors. J Natl Cancer Institute 57 (1976) 599-602
-
(1976)
J Natl Cancer Institute
, vol.57
, pp. 599-602
-
-
Robinson, R.A.1
DeVita, V.T.2
Levy, H.B.3
Baron, S.4
Hubbard, S.P.5
Levine, A.S.6
-
11
-
-
0028009931
-
-
Strayer D.R., Carter W.A., Brodsky I., Cheney P., Peterson D., Salvato P., et al. A controlled clinical trial with a specifically configured RNA drug, poly(I) poly (C12U), in chronic fatigue syndrome (1994) S88-S95
-
(1994)
A controlled clinical trial with a specifically configured RNA drug, poly(I) poly (C12U), in chronic fatigue syndrome
-
-
Strayer, D.R.1
Carter, W.A.2
Brodsky, I.3
Cheney, P.4
Peterson, D.5
Salvato, P.6
-
12
-
-
9444284910
-
Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI: polyC12U in the treatment of HIV infection
-
Thompson K.A., Strayer D.R., Salvato P.D., Thompson C.E., Klimas N., Molavi A., et al. Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI: polyC12U in the treatment of HIV infection. Eur J Clin Microbiol Infect Dis 15 7 (1996) 580-587
-
(1996)
Eur J Clin Microbiol Infect Dis
, vol.15
, Issue.7
, pp. 580-587
-
-
Thompson, K.A.1
Strayer, D.R.2
Salvato, P.D.3
Thompson, C.E.4
Klimas, N.5
Molavi, A.6
-
14
-
-
0037472447
-
Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]: poly [C12U] (Ampligen R)
-
Adams M., Navabi H., Jasani B., Man S., Fiander A., Evans A.S., et al. Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]: poly [C12U] (Ampligen R). Vaccine 21 (2003) 787-790
-
(2003)
Vaccine
, vol.21
, pp. 787-790
-
-
Adams, M.1
Navabi, H.2
Jasani, B.3
Man, S.4
Fiander, A.5
Evans, A.S.6
-
15
-
-
56949108633
-
®) promotes DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro
-
®) promotes DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro. Vaccine 27 (2009) 107-115
-
(2009)
Vaccine
, vol.27
, pp. 107-115
-
-
Navabi, H.1
Jasani, B.2
Reece, A.3
Clayton, A.4
Tabi, Z.5
Mason, M.6
-
16
-
-
0028285230
-
Proliferating dendritic cell progenitors in human blood
-
Romani N., Gruner S., Brang D., Kämpgen E., Lenz A., Trockenbacher B., et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 180 1 (1994) 83-93
-
(1994)
J Exp Med
, vol.180
, Issue.1
, pp. 83-93
-
-
Romani, N.1
Gruner, S.2
Brang, D.3
Kämpgen, E.4
Lenz, A.5
Trockenbacher, B.6
-
17
-
-
0035879893
-
A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection
-
Jonuleit H., Giesecke-Tuettenberg A., Tüting T., Thurner-Schuler B., Stuge T.B., Paragnik L., et al. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int J Cancer 93 2 (2001) 243-251
-
(2001)
Int J Cancer
, vol.93
, Issue.2
, pp. 243-251
-
-
Jonuleit, H.1
Giesecke-Tuettenberg, A.2
Tüting, T.3
Thurner-Schuler, B.4
Stuge, T.B.5
Paragnik, L.6
-
18
-
-
33745712871
-
C. Dendritic cells in a mature age
-
Sousa R.e. C. Dendritic cells in a mature age. Nat Rev Immunol 6 6 (2006) 476-483
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.6
, pp. 476-483
-
-
Sousa, R.e.1
-
19
-
-
1442348476
-
Restoration of tumor specific human leukocte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocy in patients with advanced ovarian cancer
-
Santin A.D., Bellone S., Palmieri M., Bossini B., and Pecorelli S. Restoration of tumor specific human leukocte antigens class I-restricted cytotoxicity by dendritic cell stimulation of tumor infiltrating lymphocy in patients with advanced ovarian cancer. Int J Gynecol Cancer 14 (2004) 64-75
-
(2004)
Int J Gynecol Cancer
, vol.14
, pp. 64-75
-
-
Santin, A.D.1
Bellone, S.2
Palmieri, M.3
Bossini, B.4
Pecorelli, S.5
-
20
-
-
33646356996
-
Adoptive immunotherapy for cancer: building on success
-
Gattinoni L., Powell Jr. D.J., Rosenberg S.A., and Restifo N.P. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6 5 (2006) 383-393
-
(2006)
Nat Rev Immunol
, vol.6
, Issue.5
, pp. 383-393
-
-
Gattinoni, L.1
Powell Jr., D.J.2
Rosenberg, S.A.3
Restifo, N.P.4
-
23
-
-
0242579946
-
CD8, T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine
-
Curtsinger J.M., Johnson C.M., and Mescher M.F. CD8, T cell clonal expansion and development of effector function require prolonged exposure to antigen, costimulation, and signal 3 cytokine. J Immunol 171 10 (2003) 5165-5171
-
(2003)
J Immunol
, vol.171
, Issue.10
, pp. 5165-5171
-
-
Curtsinger, J.M.1
Johnson, C.M.2
Mescher, M.F.3
-
24
-
-
14844303287
-
The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer
-
Adams M., Navabi H., Croston D., Coleman S., Tabi Z., Clayton A., et al. The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine 23 17-18 (2005) 2374-2378
-
(2005)
Vaccine
, vol.23
, Issue.17-18
, pp. 2374-2378
-
-
Adams, M.1
Navabi, H.2
Croston, D.3
Coleman, S.4
Tabi, Z.5
Clayton, A.6
-
25
-
-
2442647551
-
Dendritic cell immunotherapy: mapping the way
-
Figdor C.G., Vries I.J.d., Lesterhuis W.J., and Melief C.J. Dendritic cell immunotherapy: mapping the way. Nat Med 10 5 (2004) 475-480
-
(2004)
Nat Med
, vol.10
, Issue.5
, pp. 475-480
-
-
Figdor, C.G.1
Vries, I.J.d.2
Lesterhuis, W.J.3
Melief, C.J.4
-
26
-
-
0033697454
-
CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal.
-
Schulz O., Edwards A.D., Schito M., Aliberti J., Manickasingham S., Sher A., et al. CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 13 (2000) 453-462
-
(2000)
Immunity
, vol.13
, pp. 453-462
-
-
Schulz, O.1
Edwards, A.D.2
Schito, M.3
Aliberti, J.4
Manickasingham, S.5
Sher, A.6
-
27
-
-
4344596051
-
alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity
-
Mailliard R., Wankowicz-Kalinska A., Hilkens C., Kapsenberg M., and Kalinski P. alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res 64 (2004) 5934-5937
-
(2004)
Cancer Res
, vol.64
, pp. 5934-5937
-
-
Mailliard, R.1
Wankowicz-Kalinska, A.2
Hilkens, C.3
Kapsenberg, M.4
Kalinski, P.5
-
28
-
-
0030963666
-
Human dendritic cells require exogenous iterleukin-12 inducing factor to direct the developmentof naive T-Helper cells toward the Th1 phenotype
-
Hilkens C., Kalinski P., BoerF M.de, and Kapsenberg M. Human dendritic cells require exogenous iterleukin-12 inducing factor to direct the developmentof naive T-Helper cells toward the Th1 phenotype. Blood 90 (1997) 1920-1926
-
(1997)
Blood
, vol.90
, pp. 1920-1926
-
-
Hilkens, C.1
Kalinski, P.2
BoerF M.de3
Kapsenberg, M.4
-
30
-
-
33750286550
-
Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN
-
McBride S., Hoebe K., Georgel P., and Janssen E. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 177 9 (2006) 6122-6128
-
(2006)
J Immunol
, vol.177
, Issue.9
, pp. 6122-6128
-
-
McBride, S.1
Hoebe, K.2
Georgel, P.3
Janssen, E.4
-
31
-
-
0028145481
-
In vivo antiviral effects of mismatched double-stranded RNA on Duck Hepatitis B Virus
-
Ijichi K., Mitamura K., Ida S., Machida H., and Shimada K. In vivo antiviral effects of mismatched double-stranded RNA on Duck Hepatitis B Virus. J Med Virol 43 (1994) 161-165
-
(1994)
J Med Virol
, vol.43
, pp. 161-165
-
-
Ijichi, K.1
Mitamura, K.2
Ida, S.3
Machida, H.4
Shimada, K.5
-
32
-
-
33846090134
-
Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists.
-
Welters M.J., Bijker M.S., van den Eeden S.J., Franken K.L., Melief C.J., Offringa R., et al. Multiple CD4 and CD8 T-cell activation parameters predict vaccine efficacy in vivo mediated by individual DC-activating agonists. Vaccine 25 (2007) 1379-1389
-
(2007)
Vaccine
, vol.25
, pp. 1379-1389
-
-
Welters, M.J.1
Bijker, M.S.2
van den Eeden, S.J.3
Franken, K.L.4
Melief, C.J.5
Offringa, R.6
-
33
-
-
34247143394
-
12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules
-
12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules. J Immunol 178 (2007) 5200-5208
-
(2007)
J Immunol
, vol.178
, pp. 5200-5208
-
-
Gowen, B.B.1
Smee, D.F.2
Wong, M.H.3
Hall, J.O.4
Jung, K.H.5
Bailey, K.W.6
|